Position in RDY
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$1,760,042
+$59,332 QoQ
Shares Held
121,466
-1.1% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#5
of 58 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GREENLEAF TRUST holds $3,898,206 across 6 Drug Manufacturers - Specialty & Generic names. RDY ranks #1 (45.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDY |
Dr Reddys Laboratories Ltd
This page
|
121,466 | $1,760,042 | |
| 2 | VTRS |
Viatris Inc
|
36,589 | $581,033 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,057 | $572,714 | |
| 4 | ZTS |
Zoetis Inc.
|
4,763 | $342,269 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
1,993 | $335,900 | |
| 6 | ALKS |
Alkermes plc.
|
5,845 | $306,248 |
All Filings in RDY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,760,042 | 121,466 | Shares | Defined | 2026-07-21 | |
| 2026-03-31 | $1,700,710 | 122,795 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $1,715,463 | 122,184 | Shares | Defined | 2026-01-21 | |
| 2025-09-30 | $1,655,441 | 118,415 | Shares | Defined | 2025-10-22 | |
| 2025-06-30 | $1,780,589 | 118,469 | Shares | Defined | 2025-07-17 | |
| 2025-03-31 | $1,549,046 | 117,441 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $1,857,077 | 117,611 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $1,866,916 | 23,498 | Shares | Defined | 2024-10-22 | |
| 2024-06-30 | $1,790,312 | 23,498 | Shares | Defined | 2024-07-22 | |
| 2024-03-31 | $1,722,844 | 23,488 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $1,630,259 | 23,430 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $1,571,378 | 23,499 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $1,501,323 | 23,789 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $1,351,404 | 23,738 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $1,231,443 | 23,796 | Shares | Defined | 2023-01-25 | |
| 2022-09-30 | $1,240,615 | 23,703 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $1,310,472 | 23,659 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,416,433 | 25,416 | Shares | Defined | 2022-04-27 | |
| 2021-12-31 | $1,828,994 | 27,962 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,602,574 | 24,602 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,835,985 | 24,976 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $1,534,872 | 25,002 | Shares | Defined | 2021-04-30 | |
| 2020-12-31 | $1,782,392 | 25,002 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $1,749,573 | 25,152 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $1,320,320 | 24,907 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $997,562 | 24,735 | Shares | Defined | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||